Creating a platform to analyze and visualize cancer-related genetic data
Official title: Integrative Analysis and Visualization Platform for Cancer Regulatory Genomics
Funded at Univ of Massachusetts Med Sch Worcester · NIH-10990182 · Data updated 2026-11-12
This study is creating a user-friendly tool that looks at a lot of cancer-related genetic information to help us understand how changes in our genes can influence cancer, which could lead to better treatments and outcomes for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project start | August 12, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $416,745 |
| NIH project number | 1U01CA294209-01 |
| Project ID | NIH-10990182 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from enhanced genomic insights into their condition.
✕Less likely to help
Patients with non-cancerous conditions or those not diagnosed with any form of cancer may not receive any benefit from this research.
What this research studies
This research focuses on developing an integrative analysis and visualization platform that utilizes vast amounts of publicly available cancer genomic data. By leveraging advancements in next-generation sequencing, the project aims to uncover how genetic and epigenetic changes affect gene regulation in cancer. The platform will analyze data from various cancer types and normal tissues to identify clinically relevant regulatory elements that could inform treatment and prognosis. Patients may benefit from insights gained through this comprehensive approach to understanding cancer biology.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of cancer mechanisms and more personalized treatment options for patients.
How similar studies have gone: Previous research utilizing similar genomic analysis approaches has shown promising results in identifying new cancer subtypes and regulatory elements, indicating potential for success in this novel platform.
Where this research is happening
-
Univ of Massachusetts Med Sch Worcester
Worcester, United States Active
Researchers
- Principal investigator: Weng, Zhiping — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Weng, Zhiping
Related research
Other NIH-funded projects on the same topics.
-
Understanding HIV-1 Env shapes to boost immune attack against infected cells
Aimed at helping people living with HIV, this project explores how specific HIV-1 envelope structures attract or resist immune attack so future therapies could better help the body clear hidden virus.
-
Reprogramming metabolism to power alternative fat-burning modes
A new project will explore how fat cells burn calories in different ways to help combat obesity.
-
Silencing an Extra Chromosome to Help Down Syndrome and Related Conditions
A patient-friendly plan to use a gene-based approach to quiet an extra chromosome in cells and a mouse model to reduce disease-related effects in Down syndrome and other chromosomal imbalance disorders.
-
Gut microbes and brain function in autism
Researchers are exploring how gut bacteria may influence brain signals and behavior in autism, using worm models to uncover possible links that could someday inform human therapies.
-
Chlamydia and gonorrhea interaction: how host interferons influence co-infection
A human-health focused project looks at how the body’s interferon signals during chlamydia infection affect the way gonorrhea behaves, with potential implications for people vulnerable to both infections.
-
Conquering High Blood Pressure in Vietnamese Cities
A program to adapt and test a proven plan for lowering high blood pressure in urban Vietnam using a mobile health platform and integrated care approach.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.